Canopy Growth Corporation

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 01:30:00 29/05/2024 am IST			5-day change	1st Jan Change
11.55 ^CAD	-8.41%		-22.01%	+70.86%

16/05	Pot stocks rise as US unveils proposal to ease restrictions on marijuana	RE
16/05	US Government Reclassifies Marijuana to Less-Restrictive Category	MT

Canopy Growth Corporation announced that it expects to receive CAD 27.5 million in funding

May 02, 2024

Canopy Growth Corporation announced that it has entered into an Exchange and Subscription Agreement with new lender, MMCAP International Inc. SPC to issue Supreme Debentures maturing in September 2025 for the aggregate principal amount of CAD 27,500,000 on May 2, 2024.

Latest news about Canopy Growth Corporation

Pot stocks rise as US unveils proposal to ease restrictions on marijuana	17/05	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	16/05	MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification	16/05	DJ
Justice Department Set to Post Cannabis Reclassification Plans	16/05	MT
Investors wary of US cannabis ETFs despite recent rally	07/05	RE
Canopy USA Exercises Options to Acquire Wana, Jetty	07/05	MT
Canopy Growth Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	07/05	MT
Canopy Growth Brief: Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	07/05	MT
Canopy Growth Corporation exercised its option to acquire Wana Brands for $300 million.	07/05	CI
Canopy Growth Corporation exercised its option to acquire 75% interest in Jetty Extracts.	07/05	CI
Canopy Growth to Get $50 Million in Proceeds From Debt Accord	03/05	MT
Canopy Growth Secures US$50 Million in Financing	03/05	MT
Canopy Growth Brief: C$27.5 Millon of Debt Extended from 2025 to 2029	03/05	MT
Canopy Growth Brief: Announcing Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds	03/05	MT
Canopy Growth Corporation announced that it expects to receive CAD 27.5 million in funding	02/05	CI
TSX Closer: Market Manages a Small Gain as Focus on US Interest-Rate Decision, Powell Comments	02/05	MT
TSX Down 55 Points at Midday With Healthcare/Cannabis Stocks Posting The Biggest Declines	01/05	MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Starbucks, Super Micro Computer to Decline	01/05	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	01/05	DJ
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	01/05	MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug	01/05	MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug	01/05	MT
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug	01/05	RE
Canopy Growth Slides After Constellation Directors Leave, Share Conversion	19/04	DJ
Stocks to Watch : Canopy Growth, Metropolitan Bank, Netflix	19/04	DJ

Chart Canopy Growth Corporation

Duration

Period

More charts

Company Profile

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

Sector

Pharmaceuticals

Calendar

30/05/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Canopy Growth Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

11.55 CAD

Average target price

7.808 CAD

Spread / Average Target

-32.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
CANOPY GROWTH CORPORATION	+70.86%	694M
DONG-E-E-JIAO CO.,LTD.	+42.07%	6.28B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.20%	4.25B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.38%	3.36B
TASLY PHARMACEUTICAL GROUP CO., LTD	-16.98%	2.96B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.82%	2.45B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.47%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-12.67%	1.61B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-3.91%	1.6B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+44.56%	1.51B

Alternative Medicine